Oncopeptides AB had a revenue of 8.51M in the quarter ending Sep 30, 2024, with 4.32%. This bring the company's revenue in the last twelve months to 27.07M, Decreased 26.68%. In the fiscal year ending Dec 31, 2023, Oncopeptides AB had annual revenue of 35.22M with 321.54% growth.